Literature DB >> 9362196

Pharmacological modulation of rectal tone alters perception of distention in humans.

A Malcolm1, S F Phillips, M Camilleri, R B Hanson.   

Abstract

OBJECTIVE: Drugs can alter perception of balloon distention of the GI tract. It has been proposed that the mechanism by which this occurs is through effects on visceral afferent pathways. Our hypothesis was that modulation of rectal tone will also influence the perception of rectal balloon distention.
METHODS: Fasting and postprandial rectal tone, compliance, and perception of rectal distention were measured in 25 healthy subjects, using a five-armed, parallel, single-blinded study design. Each subject received either glucagon, nitroglycerin, clonidine, yohimbine, or saline.
RESULTS: Rectal tone, but not compliance, influenced perception as measured by balloon distention of the rectum (r = 0.6, p = 0.002). Glucagon, nitroglycerin, and clonidine reduced and yohimbine increased fasting tone compared with saline. Compliance and postprandial tone were similar in all groups. Yohimbine increased rectal perception of distention.
CONCLUSIONS: Tone is one of the factors that influences the sensory perception of balloon distention in the human rectum. Alpha2-adrenergic agents, a nitric oxide donor, and glucagon altered fasting rectal tone, but postprandial tone was similar after administration of each agent.

Entities:  

Mesh:

Year:  1997        PMID: 9362196

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  13 in total

Review 1.  Testing the sensitivity hypothesis in practice: tools and methods, assumptions and pitfalls.

Authors:  M Camilleri
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

2.  Increased beta-adrenergic sensitivity correlates with visceral hypersensitivity in patients with constipation-predominant irritable bowel syndrome.

Authors:  Jung Ho Park; Poong-Lyul Rhee; Hyun Seo Kim; Jun Haeng Lee; Young-Ho Kim; Jae Jun Kim; Jong Chul Rhee; Eun Ho Kang; Bum-Hee Yu
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

3.  Perception of and adaptation to rectal isobaric distension in patients with faecal incontinence.

Authors:  L Siproudhis; E Bellissant; F Juguet; H Allain; J F Bretagne; M Gosselin
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

Review 4.  Irritable bowel syndrome: recent and novel therapeutic approaches.

Authors:  Viola Andresen; Michael Camilleri
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 5.  Current and novel therapeutic options for irritable bowel syndrome management.

Authors:  M Camilleri; V Andresen
Journal:  Dig Liver Dis       Date:  2009-08-08       Impact factor: 4.088

Review 6.  Visceral analgesics: drugs with a great potential in functional disorders?

Authors:  Sylvie Bradesi; Jeremy Herman; Emeran A Mayer
Journal:  Curr Opin Pharmacol       Date:  2008-09-26       Impact factor: 5.547

Review 7.  Novel therapeutic approaches in IBS.

Authors:  Sylvie Bradesi; Emeran A Mayer
Journal:  Curr Opin Pharmacol       Date:  2007-11-19       Impact factor: 5.547

8.  Influence of gender, parity, and caloric load on gastrorectal response in healthy subjects: a barostat study.

Authors:  Cornelius E J Sloots; Richelle J F Felt-Bersma; Stephan G M Meuwissen; Ernst J Kuipers
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

Review 9.  Updates on treatment of irritable bowel syndrome.

Authors:  Christopher W Hammerle; Christina M Surawicz
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

10.  Rectal visceral sensitivity in women with irritable bowel syndrome without psychiatric comorbidity compared with healthy volunteers.

Authors:  Signe Spetalen; Leiv Sandvik; Svein Blomhoff; Morten B Jacobsen
Journal:  Gastroenterol Res Pract       Date:  2009-09-17       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.